IperionX: Titan Definitive Feasibility Study (DFS) Presentation

GlobeNewswire
06/10

Building a U.S. supply chain for heavy rare earths, titanium, zirconium and hafnium, delivering a U.S. critical mineral-to-metals platform for defense, aerospace, nuclear, semiconductors, robotics and advanced manufacturing supply chains

SOUTH BOSTON, Va., June 10, 2026 (GLOBE NEWSWIRE) --  IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to provide a link to the Titan Critical Mineral Project Definitive Feasibility Study (DFS) presentation.

Link: DFS Presentation


Figure 1: IperionX DFS presentation

About IperionX

IperionX is a leading American titanium metal and critical materials company – using patented metal technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, at lower energy, cost and carbon emissions.

Our Titan critical minerals project is the largest JORC-compliant mineral resource of titanium, rare earth and zircon minerals sands in the United States.

IperionX’s titanium metal and critical minerals are essential for advanced U.S. industries including space, aerospace, defense, consumer electronics, automotive and additive manufacturing.

Contacts

Anastasios (Taso) Arima, Founder and CEO
Toby Symonds, President
Dominic Allen, Chief Commercial Officer

Investors: investorrelations@iperionx.com
Media: media@iperionx.com

+1 980 237 8900
www.iperionx.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a99d8ffe-78fd-4dfa-8cfa-aff10fa16c28

A PDF accompanying this announcement is available at http://ml.globenewswire.com/Resource/Download/2f946720-8ad3-4d4a-a39a-71fa474242ed


免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10